The purpose of this paper is to explain the basis of liability for a public company, discuss the D&O marketplace with respect to IPO exposures, and set forth what you can expect from us as your broker in the process.
1 - 9 of 9 items [Currently showing All Items in Life Sciences]
One of Janet Yellen’s last acts as head of the Federal Reserve was to impose an unusual settlement condition upon Wells Fargo: as part of the consent decree, Wells Fargo would agree to the removal of four directors.
The world of cyber risk continues to develop and expand since our May 2016 paper on Medical Device Cybersecurity. The threat of ransomware has come to the forefront as demonstrated by global attacks such as Wannacry2 and Petya. These attacks show how hackers have become more sophisticated in their ability to use malware to exploit vulnerabilities in systems, hardware and devices, as well as highlighting the vulnerabilities of devices and systems that, through their lack of patching and support, and outdated operating systems, are exposed to hacking, worms, etc., that can affect patient safety, system security and data integrity.
Welcome to the winter edition of The Double Helix. Inside this issue you can find articles on the following: Medical Device Consolidation, FDA Regulations, 3D Printing and the Life Sciences Market and Clinical Trials Overseas.
Biotechnology and specifically Synthetic Biology (SynBio) is evolving at lightning speed. SynBio makes it possible to engineer life from the ground up (allowing the formation of organisms with genetic code (DNA) not found in the natural world) and to re-design existing natural bio systems for life-changing purposes. The opportunities are limitless and so are the risks.
Download the Arthur J. Gallagher & Co. Infographic for a clear, concise overview of Gallagher’s capabilities and strengths in the marketplace, from the perspectives of both Benefits & HR Consulting and Commercial Insurance & Risk Management.
Gallagher’s compensation expert, Shari Dunn, explains two core strategies in managing an organization’s human capital base: pay both competitively and cost-effectively by selecting and properly using labor market data.
This is a study of the 2014 annual proxy statement disclosures for 200 of the top U.S. companies (based on revenue and market capitalization). The study is focused on trends in short- and long-term incentive design.
Despite improvement in insurer underwriting results in 2012, the workers compensation market continues to be challenging to both employers and insurance carriers alike. To gain a broader sense of this situation, review the Gallagher Workers Compensation — Fall 2013 State of the Market whitepaper.